-
Wallance, a partner at the law firm Kaye Scholer and former chief litigation counsel to Kidder Peabody.
FORBES: Could Municipal Bonds Be the Next Financial Titanic?
-
To persuade the prevention-minded person to take a risk, recent research by psychologists Abigail Scholer, Xi Zou, Ken Fujita, Steve Stroessner, and E.
FORBES: Getting Your Boss, Colleagues, or Clients to Embrace Risk
-
Joel Greenberg, a partner at Kaye Scholer who specializes in mergers and acquisitions, believes the court ruling would be difficult to overturn on appeal.
FORBES: Market Scan
-
And what if smoking-gun e-mails turn up that show Merck knew the risks and refused to act? asks lawyer Jay Mayesh of firm Kaye Scholer.
FORBES: Merck's Mess
-
This article is by Jonathan Green, counsel in the Complex Commercial Litigation Department, and James L. Athas, who focuses his practice on government and internal investigations, at the law firm Kaye Scholer.
FORBES: Ralph Lauren Outed Its Subsidiary's Bribery and Set an Example for All
-
Black was convicted under a general charge of fraud that jurors could have reached two different ways, said Eric Susman, the prosecutor in that case and now a partner at Kaye Scholer in Chicago.
FORBES: Skilling Decision: No Get Out Of Jail Free Card
-
Jay Mayesh, a product liability defense lawyer at Kaye Scholer who represented Pfizer and Baxter International (nyse: BAX - news - people ) in drug and device litigation, at first said that it was difficult to say how bad the case would be for Merck.
FORBES: Behind Merck's Fall